1310405-41-4

Basic information

• Product Name: 3-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]-2,N-dimethylbenzamide
• Synonyms: 3-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]-2,N-dimethylbenzamide
• CAS NO: 1310405-41-4
• Molecular Weight: 359.403
• Mol File: 1310405-41-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]-2,N-dimethylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]-2,N-dimethylbenzamide(1310405-41-4)
• EPA Substance Registry System: 3-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]-2,N-dimethylbenzamide(1310405-41-4)

Safety Data

• Hazardous Substances Data: 1310405-41-4(Hazardous Substances Data)

Upstream product

• 1278250-14-8 2-(4-bromopyridin-2-yl)-1-(4-fluorophenyl)ethanone oxime 
• 1310405-49-2 3-Bromo-2,N-dimethylbenzamide 
• 1310405-48-1 2-(4-fluorophenyl)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine 
• 1278250-15-9 5-bromo-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridine 
• 1278250-13-7 2-(4-bromopyridin-2-yl)-1-(4-fluorophenyl)ethanone 
• 76006-33-2 3-bromo-2-methylbenzoic acid 
• 451-46-7 4-fluorobenzoic acid ethyl ester 
• 22282-99-1 4-bromo-2-methylpyridine 

Relevant articles and documents

DIPHENYL-PYRAZOLOPYRIDINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF AS NUCLEAR RECEPTOR NOT MODULATORS

The invention relates to a formula (I), in which R is a hydrogen or halogen atom or a (C1-C6)alkyl group; X is one or more substituents selected from a hydrogen or halogen atom, a (C1-C6)alkyl, halo(C1-C6)alkyl, (C1-C6)alkoxy, halo(C1-C6)alkoxy, cyano, hydroxy, or hydroxy(C1-C6)alkyl group; Y is a hydrogen or halogen atom or a (C1-C6)alkyl group; R1 is an NR2R3 or OR4 group; R2 and R3 independently are a hydrogen atom, a (C1-C6)alkyl, hydroxy(C1-C6)alkyl or oxo(C1-C6)alkyl group or R2 and R3, together with the nitrogen atom supporting the same, form a heterocycle optionally substituted by a (C1-C6)alkyl, hydroxy or oxo group; and R4 is a (C1-C6)alkyl, hydroxy(C1-C6)alkyl, or oxo(C1-C6)alkyl group, in the base or acid addition salt state. Said formula can be used therapeutically for treating or preventing diseases linked to the nuclear receptors Nurr-1, also known as NR4A2, NOT, TINUR, RNR-1, and HZF3.